GCSSG-SPNX: Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma: JCOG0110
Randomized Controlled Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma: JCOG0110
Sponsor: Haruhiko Fukuda
A PHASE3 clinical study on Gastric Neoplasm, this trial is completed. The trial is conducted by Haruhiko Fukuda and has accumulated 5 data snapshots since 2002. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE3
First recorded
Jun 2002
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Haruhiko Fukuda
- Ministry of Health, Labour and Welfare, Japan
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Bunkyo-ku,Honkomagome,3-18-22, Japan , Bunkyo-ku,Yushima,1-5-45, Japan , Chuo-ku,Tsukiji,5-1-1, Japan , Gifu,Kashima-cho,7-1, Japan , Hiroshima,Naka-ku,Motomachi,7-33, Japan , Itami,Koyaike,1-100, Japan , Kagoshima,Sakuragaoka,8-35-1, Japan , Kashiwa,Kashiwanoha,6-5-1, Japan , Kita-adachi,Ina,Komuro,818, Japan , Koto-ku,Ariake,3-10-6, Japan and 25 more locations